Form 4: Blend Labs Director Sells Shares Under 10b5-1 Trading Plan

A Blend Labs director, Timothy J Mayopoulos, sold 42,721 shares of Class A Common Stock at an average price of $5.0004 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Timothy J Mayopoulos, a director at Blend Labs, sold 42,721 shares of Class A Common Stock.
• The sale occurred on November 20, 2024.
• The average price per share was $5.0004.
• The shares were sold under a Rule 10b5-1 trading plan adopted on August 12, 2024.
• Following the transaction, Mr. Mayopoulos directly owns 387,620 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing for an insider stock sale under a pre-arranged plan, which is neither positive nor negative.

Industry Context

This is a routine filing for insider transactions and is common for directors and officers of public companies. The use of a 10b5-1 plan indicates the sale was pre-planned and not based on any recent material non-public information.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical insider trading activity.
• The use of a 10b5-1 trading plan is a common method for insiders to sell shares without raising concerns about trading on non-public information, and is used by directors and officers at companies such as Apple, Microsoft and Google.

Stakeholder Impact

• The sale of shares by a director may have a minor impact on shareholder sentiment, but the use of a 10b5-1 plan mitigates concerns about insider trading.

Key Dates

Keywords

Form 4, insider trading, 10b5-1 plan, stock sale, Blend Labs, BLND, director, equity securities